1.
Analysis of lung function and survival in RECAP: An open-label extension study of pirfenidone in patients with idiopathic pulmonary fibrosis. Sarcoidosis Vasc Diffuse Lung Dis [Internet]. 2014 Oct. 20 [cited 2024 Jul. 1];31(3):198-205. Available from: https://mattioli1885journals.com/index.php/sarcoidosis/article/view/3222